Literature DB >> 2274895

Teratogenic effects of maternal biotin deficiency on mouse embryos examined at midgestation.

T Watanabe1, A Endo.   

Abstract

Pregnant mice were fed a basal diet that not only did not contain biotin, but also contained the spray-dried egg white including avidin that caused the biotin deficiency. The effects of maternal biotin deficiency on craniofacial and limb development in embryos were examined at two stages of midgestation. On day 12.6 of gestation, male and female embryos weighted less and digit development was retarded in the biotin-deficient group. On day 15.6 of gestation (dg), the embryos also weighted less and external malformations, such as micrognathia (94.8%), micromelia (41.4%), and exencephaly (11.4%), were observed. The inhibition of palatal and digit formation by biotin deficiency at midgestation is responsible for later formation of cleft palate and micromelia. On dg 12.6 the liver biotin level of biotin-deficient dams was reduced to 20% of control values. Interestingly, the biotin content of the whole embryonic body was about ninefold greater than liver biotin levels in their dams.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274895     DOI: 10.1002/tera.1420420313

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  13 in total

1.  Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Lindsay Pack; Jeffery Moran; Donald M Mock
Journal:  Anal Chem       Date:  2010-05-15       Impact factor: 6.986

2.  Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans.

Authors:  Donald M Mock; Shawna L Stratton; Thomas D Horvath; Anna Bogusiewicz; Nell I Matthews; Cindy L Henrich; Amanda M Dawson; Horace J Spencer; Suzanne N Owen; Gunnar Boysen; Jeffery H Moran
Journal:  J Nutr       Date:  2011-09-14       Impact factor: 4.798

3.  Marginal biotin deficiency can be induced experimentally in humans using a cost-effective outpatient design.

Authors:  Shawna L Stratton; Cindy L Henrich; Nell I Matthews; Anna Bogusiewicz; Amanda M Dawson; Thomas D Horvath; Suzanne N Owen; Gunnar Boysen; Jeffery H Moran; Donald M Mock
Journal:  J Nutr       Date:  2011-12-07       Impact factor: 4.798

4.  Marginal biotin deficiency during normal pregnancy.

Authors:  Donald M Mock; J Gerald Quirk; Nell I Mock
Journal:  Am J Clin Nutr       Date:  2002-02       Impact factor: 7.045

Review 5.  Biotin requirements for DNA damage prevention.

Authors:  Janos Zempleni; Daniel Camara Teixeira; Toshinobu Kuroishi; Elizabeth L Cordonier; Scott Baier
Journal:  Mutat Res       Date:  2011-08-17       Impact factor: 2.433

6.  Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood.

Authors:  Tatyana I Vlasova; Shawna L Stratton; Amanda M Wells; Nell I Mock; Donald M Mock
Journal:  J Nutr       Date:  2005-01       Impact factor: 4.798

7.  Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MS.

Authors:  Thomas D Horvath; Nell I Matthews; Shawna L Stratton; Donald M Mock; Gunnar Boysen
Journal:  Anal Bioanal Chem       Date:  2011-09-03       Impact factor: 4.142

8.  Smoking accelerates biotin catabolism in women.

Authors:  Wendy M Sealey; April M Teague; Shawna L Stratton; Donald M Mock
Journal:  Am J Clin Nutr       Date:  2004-10       Impact factor: 7.045

9.  Marginal biotin deficiency is teratogenic in ICR mice.

Authors:  Donald M Mock; Nell I Mock; Christopher W Stewart; James B LaBorde; Deborah K Hansen
Journal:  J Nutr       Date:  2003-08       Impact factor: 4.798

10.  Quantitative measurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Suzanne N Owen; Donald M Mock; Jeffery H Moran
Journal:  Anal Chem       Date:  2010-10-28       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.